Aphranel is a CaHA regenerative filler innovated in China, developed at the intersection of material science and regenerative aesthetics. Inspired by structural design and the passage of time, it supports facial architecture while promoting natural regeneration. Aphranel delivers results that evolve rather than transform abruptly, with immediate structural support, collagen stimulation, and fully degradable with no residual material over time. The brand's philosophy, 'The Poetics of Time,' is about working in harmony with time to support structure, respect change, and allow beauty to unfold naturally.
We're tracking Aphranel's market expansion
How Aphranel's international expansion compares to its competitors
AphranelYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 AphranelYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Aphranel showcased CaHA filler at SAAM 2025 in Riyadh, demonstrating Chinese aesthetic medicine expertise with leading doctors. The event highlighted Aphranel's advanced technology and international expansion.
Aphranel convened a conference in Thailand, launching the MagiC Concept Global Expert Advisory Panel to advance regenerative aesthetic medicine through anatomical research and international collaboration.
Aphranel hosted a forum and runway show at Shanghai World Expo Museum, discussing regenerative aesthetics, craftsmanship, and beauty. The event highlighted the company's CaHA technology and China's first Class III medical device approval for injectable facial filler.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Aphranel's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
